Sun Pharmaceuticals earned the highest revenue from its cardic drug formulation, Rosuvas, with a value of over *** billion Indian rupees in February 2022. This was closely followed by their pain and analgesics formulation, Volini that same year.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Motilal Oswal Group. (March 8, 2022). Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 31, 2026, from /statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group. "Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees)." Chart. March 8, 2022. ÌÇÐÄÆƽâ°æ. Accessed July 31, 2026. /statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group. (2022). Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 31, 2026. /statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group. "Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by Leading Therapy Drug (in Billion Indian Rupees)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 8 Mar 2022, /statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group, Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees) ÌÇÐÄÆƽâ°æ, /statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/ (last visited July 31, 2026)
Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees) [Graph], Motilal Oswal Group, March 8, 2022. [Online]. Available: /statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
